Title
Inclusion of specified substances in dangerous drugs
Law
Ddb Board Regulation No. 4
Decision Date
Mar 26, 1987
The DDB Board Regulation No. 4, enacted on March 26, 1987, classifies substances such as Cathinone, Levamphetamine, and Pyrovalerone as Dangerous Drugs, thereby regulating their use and distribution in response to international narcotics control standards.
A

Q&A (DDB BOARD REGULATION NO. 4)

The regulation is the Dangerous Drugs Board Regulation No. 4, s. 1987, issued on March 26, 1987.

Cathinone, Levamphetamine, Levomethamphetamine, Cathine, N-Ethylamphetamine, Fenproporex, Mefenorex, Propylhexedrine, and Pyrovalerone.

The regulation is pursuant to Republic Act No. 6425, as amended, specifically Section 36 (a), Article VIII; Section 2 (e), Article I; and Section 40, Article X.

They are classified as Dangerous Drugs and further categorized as Regulated Drugs.

Yes, any quantity of these substances, including their salts, isomers (optical, positional, or geometric), and salts of isomers, regardless of the chemical, common, brand, or usual name, are covered by the regulation.

The regulation shall take effect fifteen (15) days after completion of its publication in a newspaper of general circulation once a week for two (2) consecutive weeks.

The regulation covers substances regardless of their specific chemical designation by any official, common, usual, chemical, or brand name.

Alfredo R.A. Bengzon, M.D., Secretary of Health and Chairman of the DDB, signed and adopted the regulation.

The decision of the Commission on Narcotics Drugs (S-IX) led to the issuance of this regulation.

Regulated Drugs are substances classified as Dangerous Drugs under this regulation which are controlled due to their potential for abuse and harm.


Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.